Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 156 clinical trials
Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients

Myeloproliferative neoplasms (MPNs) are blood disorders that occur when the body makes too many white or red blood cells, or platelets. This overproduction of blood cells in the bone marrow can create problems for blood flow and lead to various symptoms. One of the major problems is the formation of …

  • 0 views
  • 11 Mar, 2021
  • 1 location
Study on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic Therapy

This is a multicentric, phase IV study. In this study patients that are receiving an antineoplastic treatment and that have been diagnosed with venous thromboembolism will receive edoxaban as

carcinoma
heparin
cancer
antineoplastic agents
cancer diagnosis
  • 0 views
  • 24 Jan, 2021
  • 18 locations
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

The clinical significance of pulmonary embolism (PE) limited to the subsegmental pulmonary arteries, so called isolated subsegmental pulmonary embolism (SSPE), remains controversial. Whether isolated SSPE represents "true" PE, a clinically more benign form of PE, a physiologic lung clearing process, or a false positive result (artifact) is currently unclear and …

thrombosis
drug test
cancer
anticoagulants
rivaroxaban
  • 40 views
  • 15 Mar, 2021
  • 31 locations
A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism

venous thromboembolism and upper gastrointestinal, hepatobiliary, or pancreatic cancer, based on a group sequential design. Enrolled patients will be randomized in a 1:1 ratio. Patients will be

gastric cancer
international normalized ratio
cholangiocarcinoma
thromboplastin
anticoagulants
  • 13 views
  • 23 Jan, 2021
  • 1 location
Exercise Intolerance and Skeletal Muscle Bioenergetics in Children With Deep Venous Thrombosis

This is a prospective cohort study of 30 patients who are 8-21 years of age with venous thromboembolism (VTE)- either lower extremity deep venous thrombosis (DVT) or pulmonary embolism (PE).

embolism
thrombosis
deep venous thrombosis of lower extremity
dyspnea
thromboembolism
  • 0 views
  • 25 Jan, 2021
  • 1 location
COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial

The purpose of this study is to evaluate the safety, dose-requirements, and exploratory efficacy of twice-daily subcutaneous enoxaparin as venous thromboembolism prophylaxis in children (birth

anosmia
respiratory failure
lovenox
cough
dyspnea
  • 0 views
  • 03 Feb, 2021
  • 16 locations
Generation of Thrombin and Prediction of Deep Vein Thrombosis Post Prosthetic Orthopedic Surgery of the Lower Limbs

thrombomodulin, performed pre-surgically, could predict the risk of early venous thromboembolism after placement of total hip or knee prosthesis.

  • 0 views
  • 11 Mar, 2021
  • 1 location
Thromboembolic Risk Screening in Patients With Cancer and COVID-19

cell destruction by the virus, bacterial surinfection, cardiomyopathy or pulmonary embolism. The exact proportion of all these causes is unknown and venous thromboembolism could be a major cause

  • 0 views
  • 26 Jan, 2021
  • 6 locations
Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis

for additional 6 months. Patients were followed-up at least 1 year after anticoagulant discontinuation focusing on the study outcomes: occurrence of recurrent venous thromboembolism and

embolism
heparin
cancer
anticoagulants
thromboembolism
  • 9 views
  • 07 Nov, 2020
  • 1 location
Rivaroxaban as Thrombosis Prophylaxis in Bariatric Surgery

venous thromboembolism (VTE) prophylaxis and lung embolism with Rivaroxaban 10mg as an oral anticoagulant. After bariatric surgery patients receive the study medication Xarelto 10mg QD for 7, resp. 28

rivaroxaban 10 mg
oral anticoagulants
rivaroxaban
  • 6 views
  • 27 Jan, 2021
  • 3 locations